Rethinking Value Assessment of Preventive Health Interventions: The Health ROI Assessor Framework

ISSUE:

Health investments drive global life expectancy, quality of life and economic growth. However, there is limited progress in increasing national budget allocation to the health sector. This narrows the room for decision-making inside the sector. Health Technology Assessment (HTA) enhances efficiency in healthcare by focusing on economic burden and costs-benefit evaluation of new health interventions. Nevertheless, understanding mechanisms how health investments yield economic gains remains incomplete. Furthermore, HTA focuses on curative care, which limits the applicability to preventive measures. Urgently, new outcome measures reflecting the health sector's economic contribution are needed. This workshop describes a novel approach designed to evaluate health investments from a social and macroeconomic perspective: The Health ROI Assessor framework provides a robust metric to assess economic returns on investment in specific interventions and thus complements HTA. We aim to debate and understand the applicability to different contexts, guiding budget allocation to and within the health sector.

OVERVIEW:

Professor Ostwald will discuss systematic measurement of value creation through health investments and introduce the approach. He will share recent experience on standardized health metrics.

Professor Atun will cover new approaches of understanding preventive health interventions from a global health management and strategic health investment’s perspective. He will share his expertise in analysing health systems performance and the implementation of health reforms and medical innovations.

Murugan Varnee will discuss challenges of infectious diseases and NCDs on global health and the economy. Addressing economic and social benefits of their prevention and treatment, she will emphasize the importance of value-based health care and strong partnerships between governments and private sectors.

Carolina Goic will conduct her presentation from the perspective of a former senator and architect of the National Cancer Law in Chile. She will share her experience of policy and law making and the political processes related to investments in health.